4//SEC Filing
Payson Norman 4
Accession 0001628280-22-030749
CIK 0001551306other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:10 PM ET
Size
7.2 KB
Accession
0001628280-22-030749
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Payson Norman
Director
Transactions
- Sale
Common Stock
2022-11-22$33.80/sh−6,617$223,655→ 305,531 total(indirect: See footnote)
Holdings
- 122,493(indirect: See footnote)
Common Stock
- 12,132
Common Stock
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.40 to $34.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
- [F4]The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
Documents
Issuer
Progyny, Inc.
CIK 0001551306
Entity typeother
Related Parties
1- filerCIK 0000898544
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:10 PM ET
- Size
- 7.2 KB